Authorisation List
Authorisation List
Authorisation List
List of substances included in Annex XIV of REACH ("Authorisation List").
Companies that want to continue using a substance included in the Authorisation List after the sunset date need to prepare an application for authorisation, submit it before the latest application date and have a positive authorisation decision by the European Commission. The latest application date and the sunset date are specified in the Authorisation List.
Please be reminded that this list is provided for information purposes only. Only the text of Annex XIV as published in the Official Journal of the EU is authentic and produces legal effects.
Filter the list
The List does not contain any Substances.
with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5)
show/hide
1,2-Benzenedicarboxylic acid, mixed decyl and hexyl and octyl diesters
EC No.:
272-013-1
| CAS No.:
68648-93-1
|
-
|
-
|
46
|
27-Aug-2021
|
27-Feb-2023
|
Toxic for reproduction (Article 57c) |
Details |
covering well-defined substances and UVCB substances, polymers and homologues
show/hide
20-[4-(1,1,3,3-tetramethylbutyl)phenoxy]-3,6,9,12,15,18-hexaoxaicosan-1-ol
EC No.:
219-682-8
| CAS No.:
2497-59-8
Poly(oxy-1,2-ethanediyl), α-[(1,1,3,3-tetramethylbutyl)phenyl]-ω-hydroxy-
EC No.:
618-541-1
| CAS No.:
9036-19-5
|
-
|
-
|
42
|
04-Jul-2019
|
04-Jan-2021
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details |
substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, ethoxylated covering UVCB- and well-defined substances, polymers and homologues, which include any of the individual isomers and/or combinations thereof
show/hide
Poly (oxy-1,2-ethanediyl), alpha -(nonylphenyl)-omega-hydroxy-, branched
EC No.:
932-337-2
| CAS No.:
68412-54-4
26-(4-Nonylphenoxy)-3,6,9,12,15,18,21,24- octaoxahexacosan -1-ol
EC No.:
604-395-6
| CAS No.:
14409-72-4
Nonylphenol, branched, ethoxylated
1 - 2.5 moles ethoxylated
EC No.:
500-209-1
| CAS No.:
68412-54-4
3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-(isononylphenoxy)-
EC No.:
-
| CAS No.:
65455-72-3
Poly(oxy-1,2-ethanediyl), a-(nonylphenyl)-w-hydroxy- (CAS 9016-45-9)
EC No.:
931-562-3
| CAS No.:
9016-45-9
44-(nonylphenoxy)-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxatetratetracontanol
EC No.:
260-678-0
| CAS No.:
57321-10-5
26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol
EC No.:
255-695-5
| CAS No.:
42173-90-0
29-(nonylphenoxy)-3,6,9,12,15,18,21,24,27-nonaoxanonacosanol
EC No.:
248-294-1
| CAS No.:
27177-08-8
26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol
EC No.:
247-816-5
| CAS No.:
26571-11-9
4-Nonylphenol, branched, ethoxylated
1 - 2.5 moles ethoxylated
EC No.:
500-315-8
| CAS No.:
127087-87-0
3,6,9,12-Tetraoxatetradecan-1-ol, 14-(4-nonylphenoxy)-, branched
EC No.:
293-926-1
| CAS No.:
91648-64-5
|
-
|
-
|
43
|
04-Jul-2019
|
04-Jan-2021
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details |
covering any of the individual stereoisomers of [1] and [2] or any combination thereof
show/hide
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
EC No.:
601-499-3
| CAS No.:
117933-89-8
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EC No.:
-
| CAS No.:
676367-05-8
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-rel-
EC No.:
-
| CAS No.:
343934-04-3
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EC No.:
-
| CAS No.:
676367-09-2
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-rel-
EC No.:
-
| CAS No.:
343934-05-4
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EC No.:
-
| CAS No.:
676367-04-7
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EC No.:
-
| CAS No.:
676367-08-1
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EC No.:
-
| CAS No.:
676367-03-6
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EC No.:
-
| CAS No.:
676367-07-0
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
EC No.:
-
| CAS No.:
676367-02-5
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
EC No.:
-
| CAS No.:
676367-06-9
Reaction mass of 5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane and 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane
EC No.:
413-720-9
| CAS No.:
-
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
EC No.:
-
| CAS No.:
186309-28-4
|
-
|
-
|
50
|
27-Feb-2022
|
27-Aug-2023
|
vPvB (Article 57e) |
Details |
show/hide
|
-
|
-
|
17
|
21-Mar-2016
|
21-Sep-2017
|
Carcinogenic (Article 57a) |
Details |
and all major diastereoisomers identified
show/hide
|
-
|
-
|
03
|
21-Feb-2014
|
21-Aug-2015
|
PBT (Article 57d) |
Details |
with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl)
show/hide
Reaction product of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and phenol, heptyl derivs.
EC No.:
939-460-0
| CAS No.:
1471311-26-8
Formaldehyde, reaction products with branched and linear heptylphenol, carbon disulfide and hydrazine
EC No.:
300-298-5
| CAS No.:
93925-00-9
|
-
|
-
|
57
|
01-Nov-2023
|
01-May-2025
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details |
show/hide
Borate(2-), tetrahydroxybis[μ-(peroxy-κO1:κO2)]di-, sodium, hydrate (1:2:6)
EC No.:
-
| CAS No.:
125022-34-6
|
-
|
-
|
48
|
27-Nov-2021
|
27-May-2023
|
Toxic for reproduction (Article 57c) |
Details |
201-075-4
|
78-00-2
|
55
|
01-Nov-2023
|
01-May-2025
|
Toxic for reproduction (Article 57c) |
Details | |
201-167-4
|
79-01-6
|
15
|
21-Oct-2014
|
21-Apr-2016
|
Carcinogenic (Article 57a) |
Details | |
201-329-4
|
81-15-2
|
01
|
21-Feb-2013
|
21-Aug-2014
|
vPvB (Article 57e) |
Details | |
201-553-2
|
84-69-5
|
07
|
21-Aug-2013
|
21-Feb-2015
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |
201-557-4
|
84-74-2
|
06
|
21-Aug-2013
|
21-Feb-2015
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |
201-559-5
|
84-75-3
|
45
|
27-Aug-2021
|
27-Feb-2023
|
Toxic for reproduction (Article 57c) |
Details | |
201-622-7
|
85-68-7
|
05
|
21-Aug-2013
|
21-Feb-2015
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |
202-918-9
|
101-14-4
|
27
|
22-May-2016
|
22-Nov-2017
|
Carcinogenic (Article 57a) |
Details | |
202-974-4
|
101-77-9
|
02
|
21-Feb-2013
|
21-Aug-2014
|
Carcinogenic (Article 57a) |
Details | |
203-445-0
|
106-94-5
|
32
|
04-Jan-2019
|
04-Jul-2020
|
Toxic for reproduction (Article 57c) |
Details | |
203-458-1
|
107-06-2
|
26
|
22-May-2016
|
22-Nov-2017
|
Carcinogenic (Article 57a) |
Details | |
203-924-4
|
111-96-6
|
25
|
22-Feb-2016
|
22-Aug-2017
|
Toxic for reproduction (Article 57c) |
Details | |
204-118-5
|
115-96-8
|
13
|
21-Feb-2014
|
21-Aug-2015
|
Toxic for reproduction (Article 57c) |
Details | |
204-211-0
|
117-81-7
|
04
|
21-Aug-2013
|
21-Feb-2015
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |
204-212-6
|
117-82-8
|
37
|
04-Jan-2019
|
04-Jul-2020
|
Toxic for reproduction (Article 57c) |
Details | |
204-450-0
|
121-14-2
|
14
|
21-Feb-2014
|
21-Aug-2015
|
Carcinogenic (Article 57a) |
Details | |
205-017-9
|
131-18-0
|
38
|
04-Jan-2019
|
04-Jul-2020
|
Toxic for reproduction (Article 57c) |
Details | |
209-218-2
|
561-41-1
|
56
|
01-Nov-2023
|
01-May-2025
|
Carcinogenic (Article 57a) |
Details | |
210-088-4
|
605-50-5
|
33
|
04-Jan-2019
|
04-Jul-2020
|
Toxic for reproduction (Article 57c) |
Details | |
215-116-9
|
1303-28-2
|
09
|
21-Nov-2013
|
21-May-2015
|
Carcinogenic (Article 57a) |
Details | |
215-481-4
|
1327-53-3
|
08
|
21-Nov-2013
|
21-May-2015
|
Carcinogenic (Article 57a) |
Details | |
215-607-8
|
1333-82-0
|
16
|
21-Mar-2016
|
21-Sep-2017
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |
-
|
215-693-7
|
1344-37-2
|
11
|
21-Nov-2013
|
21-May-2015
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details |
223-346-6
|
3846-71-7
|
54
|
27-May-2022
|
27-Nov-2023
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |
223-383-8
|
3864-99-1
|
52
|
27-May-2022
|
27-Nov-2023
|
vPvB (Article 57e) |
Details | |
231-556-4
|
7632-04-4
|
49
|
27-Nov-2021
|
27-May-2023
|
Toxic for reproduction (Article 57c) |
Details | |
231-846-0
|
7758-97-6
|
10
|
21-Nov-2013
|
21-May-2015
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |
231-889-5
|
7775-11-3
|
22
|
21-Mar-2016
|
21-Sep-2017
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
Details | |
231-901-9
|
7778-39-4
|
24
|
22-Feb-2016
|
22-Aug-2017
|
Carcinogenic (Article 57a) |
Details | |
231-906-6
|
7778-50-9
|
19
|
21-Mar-2016
|
21-Sep-2017
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
Details | |
232-140-5
|
7789-00-6
|
21
|
21-Mar-2016
|
21-Sep-2017
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |
232-142-6
|
7789-06-2
|
29
|
22-Jul-2017
|
22-Jan-2019
|
Carcinogenic (Article 57a) |
Details | |
232-143-1
|
7789-09-5
|
20
|
21-Mar-2016
|
21-Sep-2017
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
Details | |
234-190-3
|
10588-01-9, 7789-12-0
|
18
|
21-Mar-2016
|
21-Sep-2017
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
Details | |
234-329-8
|
11103-86-9
|
30
|
22-Jul-2017
|
22-Jan-2019
|
Carcinogenic (Article 57a) |
Details | |
-
|
235-759-9
|
12656-85-8
|
12
|
21-Nov-2013
|
21-May-2015
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details |
239-622-4
|
15571-58-1
|
58
|
01-Nov-2023
|
01-May-2025
|
Toxic for reproduction (Article 57c) |
Details | |
246-356-2
|
24613-89-6
|
28
|
22-Jul-2017
|
22-Jan-2019
|
Carcinogenic (Article 57a) |
Details | |
246-677-8
|
25155-23-1
|
47
|
27-Nov-2021
|
27-May-2023
|
Toxic for reproduction (Article 57c) |
Details | |
247-384-8
|
25973-55-1
|
51
|
27-May-2022
|
27-Nov-2023
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |
253-037-1
|
36437-37-3
|
53
|
27-May-2022
|
27-Nov-2023
|
vPvB (Article 57e) |
Details | |
256-418-0
|
49663-84-5
|
31
|
22-Jul-2017
|
22-Jan-2019
|
Carcinogenic (Article 57a) |
Details | |
The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30°C to 180°C (86°F to 356°F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.
|
266-028-2
|
65996-93-2
|
41
|
04-Apr-2019
|
04-Oct-2020
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details |
271-084-6
|
68515-42-4
|
35
|
04-Jan-2019
|
04-Jul-2020
|
Toxic for reproduction (Article 57c) |
Details | |
271-093-5
|
68515-50-4
|
44
|
27-Aug-2021
|
27-Feb-2023
|
Toxic for reproduction (Article 57c) |
Details | |
276-158-1
|
71888-89-6
|
34
|
04-Jan-2019
|
04-Jul-2020
|
Toxic for reproduction (Article 57c) |
Details | |
284-032-2
|
84777-06-0
|
36
|
04-Jan-2019
|
04-Jul-2020
|
Toxic for reproduction (Article 57c) |
Details | |
A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300°C to 400°C (572°F to 752°F). Composed primarily of phenanthrene, anthracene and carbazole
|
292-602-7
|
90640-80-5
|
40
|
04-Apr-2019
|
04-Oct-2020
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details |
500-036-1
|
25214-70-4
|
23
|
22-Feb-2016
|
22-Aug-2017
|
Carcinogenic (Article 57a) |
Details | |
915-270-3
|
-
|
59
|
01-Nov-2023
|
01-May-2025
|
Toxic for reproduction (Article 57c) |
Details | |
933-378-9
|
776297-69-9
|
39
|
04-Jan-2019
|
04-Jul-2020
|
Toxic for reproduction (Article 57c) |
Details | |
EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.